Cons
- Clinical risk
- expensive trials ($40m+ each) considering 100+ patients
- FDA being very picky on Novel treatments as we have seen with MSB
- Time - long timelines before applications can be submitted
I haven't worked through many of the Pro's yet, but will be following the thread to learn more
IMU: investment pros and cons, page-6
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.003(4.84%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 6.1¢ | 6.3¢ | 5.8¢ | $2.926M | 48.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1489666 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 1250588 | 5 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |